The CMS administrator’s comments at an industry event in D.C. on Wednesday reflect the difficult tightrope regulators in the Trump administration walk as they pursue MA reform.
Oz reiterates need to improve Medicare Advantage payment accuracy Read More »
Novo Nordisk struck another deal, this time with Omeros, amid a broader pipeline restructuring that recently claimed its cell therapy work.
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work Read More »
This webinar, tailored for scientists in academia, biotech, and pharma, explores how intelligent mRNA designs can reduce experimental workloads and improve mRNA performance and efficacy.
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
Abbott CEO: ‘We’re right on time’ to the PFA party Read More »
Gov. Gavin Newsom signed an array of healthcare bills into law last week that crack down on pharmacy benefit managers and beef up the review process for deals involving private equity firms.
California passes laws targeting PBMs, private equity Read More »
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
Stereotaxis teams with CardioFocus to develop robotic PFA system Read More »
Despite announcing a broad pivot to siRNA earlier this year, Sarepta is following through with an investigational gene therapy: its limb-girdle muscular dystrophy candidate. But the treatment’s path forward, analysts say, is highly uncertain.
Sarepta’s Not Done With Gene Therapy Yet as LGMD Asset Yields Promising Data Read More »
After beating Novo Nordisk’s semaglutide last month, Lilly’s much anticipated oral candidate orforglipron has taken down AstraZeneca’s Farxiga in a head-to-head trial.
Lilly’s Oral GLP-1 Bests Another Big Pharma Bestseller in Phase III Diabetes Trial Read More »
The drugstore retailer will also bring on more than 3,500 employees from the rival chain and make “targeted investments” in its own stores.
As providers and payers navigate an increasingly challenging financial environment, executives are targeting AI tools that show a clear return on investment, according to a report by Klas Research and Bain & Company.
Healthcare AI investment focused on profit margins, ROI: report Read More »
